The Oncotarget project is a large journal which has now migrated from bi-weekly to weekly publication. This has been an exponential growth from eight issues published in 2010 when it was founded to weekly releases within just six short years in 2016. This exponential growth has enabled readers to get a broad range of information on oncology and cancer research and papers through the weekly journal. The study of cancer and more specifically oncology is regarded as some of the most important areas of scientific research in the modern medical field. Two people are at the center of this all important development. These are the chief editors of Oncotarget Andrei V. Gudkov and Mikhail V. Blagosklonny. Both these committed cancer and oncology researchers work at the Buffalo based Roswell Cancer Institute and dedicate their time to the editing and publication of the journal in a timely and efficient manner.
The two chief editors are highly respected in the field of cancer research, and each of them has specialized their efforts to specific areas of research. Andrei V. Gudkov is more concerned with the discovery of new drugs on scimagorjr.com which may be used in the treatment in the areas of gene discovery, cancer treatment and the enhancement of the use of molecular targets while treating cancer. Mr. Andrei V. Gudkov took his studies in the Moscow State University and furthered them at the National Cancer Institute. His colleague Mikhail V. Blagosklonny is more concerned with studies majoring on signal transduction, clinical investigation, cellular senescence, cell cycle studies and molecular biology. He is also concerned with anticancer therapeutics, attempting to determine new ways of cancer treatment using basic scientific methods.
Oncotarget.com, one of his most recent projects was able to prove a connection between signal transduction pathways which have been used extensively in cancer treatment and aging. This has been hailed as a significant step towards the treatment of aging related diseases and aging itself.The two chief editors Andrei V. Gudkov and Mikhail V. Blagosklonny have used their extensive training and knowledge in cancer-related research to direct and oversee the publication of Oncotarget each week. They ensure to use this training and experience to ensure that the information carried in the journal is factual, recent and helpful to readers, serving to offer much-needed insight into the treatment of the disease, which is one of the greatest cause of the death of the 21st century.